Results 221 to 230 of about 106,594 (302)

Gastroesophageal Reflux, Sleep-Disordered Breathing, and Outcomes in Patients With Idiopathic Pulmonary Fibrosis. [PDF]

Can Respir J
Ellis B, Morris D, Peterson A, Marquetti I, Manietta L, Borg M, Halliday S, Malik A, Sandbo N, Gangnon R, Francois CJ, Teodorescu M.   +11 more
europepmc   +1 more source

Regulated Cell Death in Idiopathic Pulmonary Fibrosis

The FASEB Journal, Volume 40, Issue 9, 15 May 2026.
This graphical abstract illustrates regulated cell death (RCD) across key pulmonary cell types—including alveolar epithelial cells, fibroblasts, macrophages, and endothelial cells—modulated through a dynamic death modulation network within the IPF microenvironment.
Xiaoyue Pan, Liu Yang, Man Zhao, Yanlin Zhou, Cong Xia, Huibing Liu, Yuqi Wang, Hui Lian, Bin Li, Lan Wang, Guoying Yu   +10 more
wiley   +1 more source

Biomarkers of mitochondrial dynamics in idiopathic pulmonary fibrosis: Identification and validation through transcriptomic and single-cell analyses. [PDF]

PLoS One
Wang Y, Cheng P, Meng Z, Zhang Y, Li Y, Feng F.   +5 more
europepmc   +1 more source

Investigating the impact of key algorithm parameters and patient‐specific factors on the accuracy of CT ventilation imaging

Journal of Applied Clinical Medical Physics, Volume 27, Issue 5, May 2026.
Abstract Background Computed Tomography Ventilation Imaging (CTVI) is an investigational technique that has its basis in functional lung avoidance radiotherapy. It offers a cost‐effective and accessible alternative to nuclear medicine imaging by generating lung ventilation maps from 4DCT or paired inhale/exhale breath‐hold CT (BHCT) scans. Despite over
Jeremy Lim, John Kipritidis, Jeremy T. Booth, Paul J. Keall, Hilary L. Byrne   +4 more
wiley   +1 more source

Computational Modeling Meets 3D Bioprinting: Emerging Synergies in Cardiovascular Disease Modeling

Advanced Healthcare Materials, Volume 15, Issue 17, 8 May 2026.
Emerging advances in three‐dimensional bioprinting and computational modeling are reshaping cardiovascular (CV) research by enabling more realistic, patient‐specific tissue platforms. This review surveys cutting‐edge approaches that merge biomimetic CV constructs with computational simulations to overcome the limitations of traditional models, improve ...
Tanmay Mukherjee, Mehdi Salar Amoli, Sarah Rezapourdamanab, Lama Rita El Shammas, Martin L. Tomov, Emilio A. Mendiola, Vahid Serpooshan, Reza Avazmohammadi   +7 more
wiley   +1 more source

Idiopathic pulmonary fibrosis predicts local recurrence following surgery in patients with non-small cell lung cancer. [PDF]

J Cancer Res Clin Oncol
Maeda R, Inomata M, Hazemoto T, Yamada R.   +3 more
europepmc   +1 more source

Chronic Hypoxia Disrupts Spermatogenesis Through ASXL2–EZH2–Mediated Microtubule Destabilization

Advanced Science, Volume 13, Issue 26, 8 May 2026.
This study reveals the mechanism by which chronic hypoxia impairs spermatogenesis via the ASXL2–EZH2 axis, hindering the transition of spermatids from round to elongated forms. Key findings reveal that under hypoxic conditions, downregulated ASXL2 expression reduces EZH2 binding to the CEP162 promoter, leading to decreased H3K27me3 modification and ...
Jun Yin, Mengjie Zhang, Wenying Liu, Wenlong Shen, Debao Li, Hongming Miao, Fang Deng, Gang Zhang, Yi Tian, Yi Zhang, Zhihu Zhao, Bing Ni   +11 more
wiley   +1 more source

Idiopathic Pulmonary Fibrosis: Analysis of Predisposing Variants in Patients with Familial Forms. [PDF]

Biomedicines
Stanghellini I, Bonora E, Sebastiani M, Salvarani C, Gozzi F, Andrisani D, Tonelli R, Rizzardi N, Bergamini C, Isidori F, Seri M, Clini E, Cerri S, Calabrese O.   +13 more
europepmc   +1 more source

Decoding the Cardiac Immune Microenvironment and Fibroblast Crosstalk in Radiotherapy Combined with Immunotherapy‐Induced Cardiac Fibrosis Based on Single‐Cell Transcriptomic Analysis

Advanced Science, Volume 13, Issue 25, 4 May 2026.
This study highlights that radioimmunotherapy drives crosstalk between fibroblasts and immune cells (especially macrophages) in the cardiac microenvironment, with IL‐6 as the key mediator, and tocilizumab alleviates cardiac fibrosis by targeting this interplay.
Yuxi Luo, Ying Yu, Zhimin Zeng, Yanxin Chen, Yali Yi, Zhiqin Lu, Fujuan Zeng, Peng Xu, Daya Luo, Leifeng Chen, Anwen Liu   +10 more
wiley   +1 more source